Sex-different hepatic glycogen content and glucose output in rats

BMC Biochemistry - Tập 11 - Trang 1-17 - 2010
Carolina Gustavsson1, Kamal Yassin1, Erik Wahlström2, Louisa Cheung1, Johan Lindberg2, Kerstin Brismar1, Claes-Göran Östenson1, Gunnar Norstedt1, Petra Tollet-Egnell1
1Department of Molecular Medicine and Surgery, Karolinska Institutet, Sweden
2Molecular Toxicology, Safety Assessment, Astra Zeneca R&D, Sweden

Tóm tắt

Genes involved in hepatic metabolism have a sex-different expression in rodents. To test whether male and female rat livers differ regarding lipid and carbohydrate metabolism, whole-genome transcript profiles were generated and these were complemented by measurements of hepatic lipid and glycogen content, fatty acid (FA) oxidation rates and hepatic glucose output (HGO). The latter was determined in perfusates from in situ perfusion of male and female rat livers. These perfusates were also analysed using nuclear magnetic resonance (NMR) spectroscopy to identify putative sex-differences in other liver-derived metabolites. Effects of insulin were monitored by analysis of Akt-phosphorylation, gene expression and HGO after s.c. insulin injections. Out of approximately 3 500 gene products being detected in liver, 11% were significantly higher in females, and 11% were higher in males. Many transcripts for the production of triglycerides (TG), cholesterol and VLDL particles were female-predominant, whereas genes for FA oxidation, gluconeogenesis and glycogen synthesis were male-predominant. Sex-differences in mRNA levels related to metabolism were more pronounced during mild starvation (12 h fasting), as compared to the postabsorptive state (4 h fasting). No sex-differences were observed regarding hepatic TG content, FA oxidation rates or blood levels of ketone bodies or glucose. However, males had higher hepatic glycogen content and higher HGO, as well as higher ratios of insulin to glucagon levels. Based on NMR spectroscopy, liver-derived lactate was also higher in males. HGO was inhibited by insulin in parallel with increased phosphorylation of Akt, without any sex-differences in insulin sensitivity. However, the degree of Thr172-phosphorylated AMP kinase (AMPK) was higher in females, indicating a higher degree of AMPK-dependent actions. Taken together, males had higher ratios of insulin to glucagon levels, higher levels of glycogen, lower degree of AMPK phosphorylation, higher expression of gluconeogenic genes and higher hepatic glucose output. Possibly these sex-differences reflect a higher ability for the healthy male rat liver to respond to increased energy demands.

Tài liệu tham khảo

Rogol AD, Roemmich JN, Clark PA: Growth at puberty. Journal of Adolescent Health. 2002, 31 (6, Supplement 1): 192-200. 10.1016/S1054-139X(02)00485-8. Loomba-Albrecht L, Styne D: Effect of puberty on body composition. Curr Opin Endocrinol Diabetes Obes. 2009, 16 (1): 10-15. Geer EB, Shen W: Gender differences in insulin resistance, body composition, and energy balance. Gender Medicine. 2009, 6 (Part 1): 60-75. 10.1016/j.genm.2009.02.002. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen M-R, Groop L: Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome. Diabetes Care. 2001, 24 (4): 683-689. 10.2337/diacare.24.4.683. Legato MJ, Gelzer A, Goland R, Ebner SA, Rajan S, Villagra V, Kosowski M: Gender-specific care of the patient with diabetes: Review and recommendations. Gender Medicine. 2006, 3 (2): 131-158. 10.1016/S1550-8579(06)80202-0. Regitz-Zagrosek V, Lehmkuhl E, Mahmoodzadeh S: Gender Aspects of the Role of the Metabolic Syndrome as a Risk Factor for Cardiovascular Disease. Gender Medicine. 2007, 4 (Supplement 2): S162-S177. 10.1016/S1550-8579(07)80056-8. Moran A, Jacobs DR, Steinberger J, Steffen LM, Pankow JS, Hong C-P, Sinaiko AR: Changes in Insulin Resistance and Cardiovascular Risk During Adolescence: Establishment of Differential Risk in Males and Females. Circulation. 2008, 117 (18): 2361-2368. 10.1161/CIRCULATIONAHA.107.704569. Cheung O, Sanyal A: Recent advances in nonalcoholic fatty liver disease. Curr Opin Gastroenterol. 2010, Kim HJ, Kim HJ, Lee KE, Kim DJ, Kim SK, Ahn CW, Lim S-K, Kim KR, Lee HC, Huh KB: Metabolic Significance of Nonalcoholic Fatty Liver Disease in Nonobese, Nondiabetic Adults. Arch Intern Med. 2004, 164 (19): 2169-2175. 10.1001/archinte.164.19.2169. Kuhl J, Hilding A, Östenson CG, Grill V, Efendic S, Båvenholm P: Characterisation of subjects with early abnormalities of glucose tolerance in the Stockholm Diabetes Prevention Programme: the impact of sex and type 2 diabetes heredity. Diabetologia. 2005, 48 (1): 35-40. 10.1007/s00125-004-1614-1. Bryzgalova G, Gao H, Ahren B, Zierath JR, Galuska D, Steiler TL, Dahlman-Wright K, Nilsson S, Gustafsson JÅ, Efendic S: Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia. 2006, 1-10. Stahlberg N, Rico-Bautista E, Fisher RM, Wu X, Cheung L, Flores-Morales A, Tybring G, Norstedt G, Tollet-Egnell P: Female-Predominant Expression of Fatty Acid Translocase/CD36 in Rat and Human Liver. Endocrinology. 2004, 145 (4): 1972-1979. 10.1210/en.2003-0874. Ahluwalia A, Clodfelter KH, Waxman DJ: Sexual Dimorphism of Rat Liver Gene Expression: Regulatory Role of Growth Hormone Revealed by Deoxyribonucleic Acid Microarray Analysis. Mol Endocrinol. 2004, 18 (3): 747-760. 10.1210/me.2003-0138. Yang X, Schadt EE, Wang S, Wang H, Arnold AP, Ingram-Drake L, Drake TA, Lusis AJ: Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res. 2006, 16 (8): 995-1004. 10.1101/gr.5217506. Tarnopolsky M, Ruby B: Sex differences in carbohydrate metabolism. Current Opinion in Clinical Nutrition and Metabolic Care. 2001, 4 (6): 521-526. 10.1097/00075197-200111000-00010. Svoboda D, Azarnoff D, Reddy J: Microbodies in experimentally altered cells: II. The Relationship of Microbody Proliferation to Endocrine Glands. The Journal of Cell Biology. 1969, 40 (3): 734-746. 10.1083/jcb.40.3.734. Hawkins J, Jones W, Bonner F, Gibson G: The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney. Drug Metab Rev. 1987, 18 (4): 441-515. 10.3109/03602538708994130. Kawashima Y, Uy-Yu N, Kozuka H: Sex-related differences in the enhancing effects of perfluoro-octanoic acid on stearoyl-CoA desaturase and its influence on the acyl composition of phospholipid in rat liver. Comparison with clofibric acid and tiadenol. the Biochemical Journal. 1989, 263 (3): 897-904. Kawashima Y, Uy-Yu N, Kozuka H: Sex-related difference in the inductions by perfluoro-octanoic acid of peroxisomal beta-oxidation, microsomal 1-acylglycerophosphocholine acyltransferase and cytosolic long-chain acyl-CoA hydrolase in rat liver. the Biochemical Journal. 1989, 261 (2): 595-600. Houstis N, Rosen ED, Lander ES: Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006, 440 (7086): 944-948. 10.1038/nature04634. Kushlan MC, Gollan JL, Ma W-L, Ockner RK: Sex differences in hepatic uptake of long chain fatty acids in single-pass perfused rat liver. J Lipid Res. 1981, 22 (3): 431-436. Gustavsson C, Parini P, Ostojic J, Cheung L, Hu J, Zadjali F, Tahir F, Brismar K, Norstedt G, Tollet-Egnell P: Cocoa Butter and Safflower Oil Elicit Different Effects on Hepatic Gene Expression and Lipid Metabolism in Rats. Lipids. 2009 Folch J, Lees M, Stanley GHS: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957, 226 (1): 497-509. Kohlmeier M: Direct enzymic measurement of glycerides in serum and in lipoprotein fractions. Clin Chem. 1986, 32 (1): 63-66. Doi Y, Iwai M, Matsuura B, Onji M: Glucagon attenuates the action of insulin on glucose output in the liver of the Goto-Kakizaki rat perfused in situ. Pflugers Arch. 2001, 442 (4): 537-541. 10.1007/s004240100573. Meiboom S, Gill D: Modified Spin-Echo Method for Measuring Nuclear Relaxation Times. Rev Sci Instrum. 1958, 29 (688): Nowick JS, Khakshoor O, Hashemzadeh M, Brower JO: DSA: A New Internal Standard for NMR Studies in Aqueous Solution. Organic Letters. 2003, 5 (19): 3511-3513. 10.1021/ol035347w. Alum M, Shaw P, Sweatman B, Ubhi B, Haselden J, Connor S: 4,4-Dimethyl-4-silapentane-1-ammonium trifluoroacetate (DSA), a promising universal internal standard for NMR-based metabolic profiling studies of biofluids, including blood plasma and serum. Metabolomics. 2008, 4: 122-127. 10.1007/s11306-008-0103-9. Weljie AM, Newton J, Mercier P, Carlson E, Slupsky CM: Targeted Profiling: Quantitative Analysis of 1 H NMR Metabolomics Data. Analytical Chemistry. 2006, 78 (13): 4430-4442. 10.1021/ac060209g. Soler-Argilaga C, Danon A, Goh E, Wilcox HG, Heimberg M: The effect of sex on the uptake of very low density lipoprotein triglyceride fatty acid from the plasma of the rat in vivo. Biochemical and Biophysical Research Communications. 1975, 66 (4): 1237-1242. 10.1016/0006-291X(75)90491-X. Soler-Argilaga C, Heimberg M: Comparison of metabolism of free fatty acid by isolated perfused livers from male and female rats. J Lipid Res. 1976, 17 (6): 605-615. Chatterjee B, Demyan W, Gustafsson J, Harris M, Hökfelt T, Norstedt G, Roy A: Effect of anterior hypothalamic deafferentation and continuous growth hormone infusion on the hepatic synthesis of alpha 2u-globulin in the male rat. J Endocrinol. 1986, 108: 351-355. 10.1677/joe.0.1080351. Moran JH, Mitchell LA, Bradbury JA, Qu W, Zeldin DC, Schnellmann RG, Grant DF: Analysis of the Cytotoxic Properties of Linoleic Acid Metabolites Produced by Renal and Hepatic P450s. Toxicol Appl Pharmacol. 2000, 168 (3): 268-279. 10.1006/taap.2000.9053. Ryan D, Iida S, Wood A, Thomas P, Lieber C, Levin W: Characterization of three highly purified cytochromes P-450 from hepatic microsomes of adult male rats. J Biol Chem. 1984, 259 (2): 1239-1250. Gardmo C, Persson B, Mode A: Cloning of a Novel Growth Hormone-Regulated Rat Complementary Deoxyribonucleic Acid with Homology to the Human alpha1B-Glycoprotein, Characterizing a New Protein Family. Endocrinology. 2001, 142 (6): 2695-2701. 10.1210/en.142.6.2695. Frystyk J, Gronbak H, Skjarbak C, Flyvbjerg A, Orskov H, Baxter RC: Developmental Changes in Serum Levels of Free and Total Insulin-Like Growth Factor I (IGF-I), IGF-Binding Protein-1 and -3, and the Acid-Labile Subunit in Rats. Endocrinology. 1998, 139 (10): 4286-4292. 10.1210/en.139.10.4286. Norstedt G, Eneroth P, Gustafsson J-Å, Hökfelt T, Skett P: Hypothalamopituitary regulation of hepatic prolactin receptors in the rat. Brain Research. 1980, 192 (1): 77-88. 10.1016/0006-8993(80)91010-0. Lahuna O, Fernandez L, Karlsson H, Maiter D, Lemaigre FP, Rousseau GG, Gustafsson J-Å, Mode A: Expression of hepatocyte nuclear factor 6 in rat liver is sex-dependent and regulated by growth hormone. Proceedings of the National Academy of Sciences of the United States of America. 1997, 94 (23): 12309-12313. 10.1073/pnas.94.23.12309. Mode A, Wiersma-Larsson E, Gustafsson J-Å: Transcriptional and posttranscriptional regulation of sexually differentiated rat liver cytochrome P-450 by growth hormone. Mol Endocrinol. 1989, 3: 1142-1147. 10.1210/mend-3-7-1142. Bandiera S, Ryan D, Levin W, Thomas P: Age- and sex-related expression of cytochromes p450f and P450g in rat liver. Arch Biochem Biophys. 1986, 248 (2): 658-676. 10.1016/0003-9861(86)90521-7. Hardie DG: The AMP-activated protein kinase pathway - new players upstream and downstream. J Cell Sci. 2004, 117 (23): 5479-5487. 10.1242/jcs.01540. McBride A, Ghilagaber S, Nikolaev A, Hardie DG: The Glycogen-Binding Domain on the AMPK beta Subunit Allows the Kinase to Act as a Glycogen Sensor. Cell Metabolism. 2009, 9 (1): 23-34. 10.1016/j.cmet.2008.11.008. Uotani S, Abe T, Yamaguchi Y: Leptin activates AMP-activated protein kinase in hepatic cells via a JAK2-dependent pathway. Biochemical and Biophysical Research Communications. 2006, 351 (1): 171-175. 10.1016/j.bbrc.2006.10.015. Awazawa M, Ueki K, Inabe K, Yamauchi T, Kaneko K, Okazaki Y, Bardeesy N, Ohnishi S, Nagai R, Kadowaki T: Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway. Biochemical and Biophysical Research Communications. 2009, 382 (1): 51-56. 10.1016/j.bbrc.2009.02.131. Degrace P, Moindrot B, Mohamed I, Gresti J, Du Z-Y, Chardigny J-M, Sebedio JL, Clouet P: Upregulation of liver VLDL receptor and FAT/CD36 expressions in LDLR-/- apoB100/100 mice fed trans-10, cis-12 conjugated linoleic acid. J Lipid Res. 2006, 47 (12): 2647-2655. 10.1194/jlr.M600140-JLR200. Zhou J, Zhai Y, Mu Y, Gong H, Uppal H, Toma D, Ren S, Evans RM, Xie W: A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway. J Biol Chem. 2006, 281 (21): 15013-15020. 10.1074/jbc.M511116200. Cheung L, Andersen M, Gustavsson C, Odeberg J, Fernandez-Perez L, Norstedt G, Tollet-Egnell P: Hormonal and nutritional regulation of alternative CD36 transcripts in rat liver - a role for growth hormone in alternative exon usage. BMC Molecular Biology. 2007, 8 (1): 60-10.1186/1471-2199-8-60. Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W: From molecular action to physiological outputs: Peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Progress in Lipid Research. 2006, 45 (2): 120-159. 10.1016/j.plipres.2005.12.002. Desvergne B, Wahli W: Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism. Endocr Rev. 1999, 20 (5): 649-688. 10.1210/er.20.5.649. Reddy JK: Nonalcoholic Steatosis and Steatohepatitis: III. Peroxisomal betaoxidation, PPARalpha, and steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2001, 281 (6): G1333-1339. Rodriguez JC, Gil-Gomez G, Hegardt FG, Haro D: Peroxisome proliferatoractivated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. J Biol Chem. 1994, 269 (29): 18767-18772. Jalouli M, Carlsson L, Ameen C, Linden D, Ljungberg A, Michalik L, Eden S, Wahli W, Oscarsson J: Sex Difference in Hepatic Peroxisome Proliferator-Activated Receptor alpha Expression: Influence of Pituitary and Gonadal Hormones. Endocrinology. 2003, 144 (1): 101-109. 10.1210/en.2002-220630. Djouadi F, Weinheimer CJ, Saffitz JE, Pitchford C, Bastin J, Gonzalez FJ, Kelly DP: A Gender-related Defect in Lipid Metabolism and Glucose Homeostasis in Peroxisome Proliferator- activated Receptor alpha - deficient Mice. J Clin Invest. 1998, 102 (6): 1083-1091. 10.1172/JCI3949. Bernal-Mizrachi C, Weng S, Feng C, Finck B, Knutsen R, Leone T, Coleman T, Mecham R, Kelly D, Semenkovich C: Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice. Nat Med. 2003, 9 (8): 1069-1075. 10.1038/nm898. Koo S, Satoh H, Herzig S, Lee C, Hedrick S, Kulkarni R, Evans R, Olefsky J, Montminy M: PGC-1 promotes insulin resistance in liver through PPARalpha-dependent induction of TRB-3. Nat Med. 2004, 10 (5): 530-534. 10.1038/nm1044. Patsouris D, Mandard S, Voshol P, Escher P, Tan N, Havekes L, Koenig W, März W, Tafuri S, Wahli W: PPARalpha governs glycerol metabolism. J Clin Invest. 2004, 114 (1): 94-103. Bernal-Mizrachi C, Xiaozhong L, Yin L, Knutsen R, Howard M, Arends J, P D, Coleman T, Semenkovich C: An afferent vagal nerve pathway links hepatic PPARalpha activation to glucocorticoid-induced insulin resistance and hypertension. Cell Metab. 2007, 5 (2): 91-102. 10.1016/j.cmet.2006.12.010. Kersten S, Seydoux J, Peters J, Gonzalez F, Desvergne B, Wahli W: Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest. 1999, 103 (11): 1489-1498. 10.1172/JCI6223. Teutsch H: Sex-specific regionality of liver metabolism during starvation; with special reference to the heterogeneity of the lobular periphery. Histochemistry. 1984, 81 (1): 87-92. 10.1007/BF00495406. Wimmer M: The effect of sex hormones on the acinar distribution pattern of phosphoenolpyruvate carboxykinase activity in rat liver. Biol Chem Hoppe Seyler. 1989, 370 (7): 683-690. Matute M, Kalkhoff R: Sex steroid influence on hepatic gluconeogenesis and glucogen formation. Endocrinology. 1973, 92 (3): 762-768. 10.1210/endo-92-3-762. Borthwick E, Houston M, Coughtrie M, Burchell A: The antihyperglycemic effect of estrone sulfate in genetically obese-diabetic (ob/ob) mice is associated with reduced hepatic glucose-6-phosphatase. Horm Metab Res. 2001, 33 (12): 721-726. 10.1055/s-2001-19136. Isaksson OGP, Eden S, Jansson J: Mode of Action of Pituitary Growth Hormone on Target Cells. Annual Review of Physiology. 1985, 47 (1): 483-499. 10.1146/annurev.ph.47.030185.002411. Rose S, Municchi G, Barnes K, Kamp G, Uriarte M, Ross J, Cassorla F, Cutler GJ: Spontaneous growth hormone secretion increases during puberty in normal girls and boys. J Clin Endocrinol Metab. 1991, 73 (2): 428-435. 10.1210/jcem-73-2-428. Clark RG, Jansson JO, Isaksson O, Robinson IC: Intravenous growth hormone: growth responses to patterned infusions in hypophysectomized rats. J Endocrinol. 1985, 104 (1): 53-61. 10.1677/joe.0.1040053. Zaphiropoulos PG, Mode A, Norstedt G, Gustafsson J-Å: Regulation of sexual differentiation in drug and steroid metabolism. Trends Pharmacol Sci. 1989, 10: 149-153. 10.1016/0165-6147(89)90167-3. Ameen C, Linden D, Larsson B-M, Mode A, Holmang A, Oscarsson J: Effects of gender and GH secretory pattern on sterol regulatory element-binding protein-1c and its target genes in rat liver. Am J Physiol Endocrinol Metab. 2004, 287 (6): E1039-1048. 10.1152/ajpendo.00059.2004. Tollet-Egnell P, Flores-Morales A, Stahlberg N, Malek RL, Lee N, Norstedt G: Gene Expression Profile of the Aging Process in Rat Liver: Normalizing Effects of Growth Hormone Replacement. Mol Endocrinol. 2001, 15 (2): 308-318. 10.1210/me.15.2.308. Sjoberg A, Oscarsson J, Boren J, Eden S, Olofsson SO: Mode of growth hormone administration influences triacylglycerol synthesis and assembly of apolipoprotein B-containing lipoproteins in cultured rat hepatocytes. J Lipid Res. 1996, 37 (2): 275-289. Elam MB, Simkevich CP, Solomon SS, Wilcox HG, Heimberg M: Stimulation of in Vitro Triglyceride Synthesis in the Rat Hepatocyte by Growth Hormone Treatment in Vivo. Endocrinology. 1988, 122 (4): 1397-1402. 10.1210/endo-122-4-1397. Frick F, Linden D, Ameen C, Eden S, Mode A, Oscarsson J: Interaction between growth hormone and insulin in the regulation of lipoprotein metabolism in the rat. Am J Physiol Endocrinol Metab. 2002, 283 (5): E1023-1031. Flores-Morales A, Stahlberg N, Tollet-Egnell P, Lundeberg J, Malek RL, Quackenbush J, Lee NH, Norstedt G: Microarray Analysis of the in Vivo Effects of Hypophysectomy and Growth Hormone Treatment on Gene Expression in the Rat. Endocrinology. 2001, 142 (7): 3163-3176. 10.1210/en.142.7.3163. Yamada J, Sugiyama H, Watanabe T, Suga T: Suppressive effect of growth hormone on the expression of peroxisome proliferator-activated receptor in cultured rat hepatocytes. Res Commun Mol Pathol Pharmacol. 1995, 90 (1): 173-176. Xu A, Lam MC, Chan KW, Wang Y, Zhang J, Hoo RLC, Xu JY, Chen B, Chow W-S, Tso AWK: Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proceedings of the National Academy of Sciences of the United States of America. 2005, 102 (17): 6086-6091. 10.1073/pnas.0408452102. Dutton S, Trayhurn P: Regulation of angiopoietin-like protein 4/fastinginduced adipose factor (Angptl4/FIAF) expression in mouse white adipose tissue and 3T3-L1 adipocytes. British Journal of Nutrition. 2008, 100 (01): 18-26. 10.1017/S0007114507882961. Mandard Sp, Zandbergen F, van Straten E, Wahli W, Kuipers F, Müller M, Kersten S: The Fasting-induced Adipose Factor/Angiopoietin-like Protein 4 Is Physically Associated with Lipoproteins and Governs Plasma Lipid Levels and Adiposity. Journal of Biological Chemistry. 2006, 281 (2): 934-944. 10.1074/jbc.M506519200. Lichtenstein L, Berbee JFP, van Dijk SJ, van Dijk KW, Bensadoun A, Kema IP, Voshol PJ, Müller M, Rensen PCN, Kersten S: Angptl4 Upregulates Cholesterol Synthesis in Liver via Inhibition of LPL- and HL-Dependent Hepatic Cholesterol Uptake. Arterioscler Thromb Vasc Biol. 2007, 27 (11): 2420-2427. 10.1161/ATVBAHA.107.151894. Tarnopolsky M: Gender differences in metabolism; nutrition and supplements. Journal of Science and Medicine in Sport. 2000, 3 (3): 287-298. 10.1016/S1440-2440(00)80038-9. Devries M, Hamadeh M, Phillips S, Tarnopolsky M: Menstrual cycle phase and sex influence muscle glycogen utilization and glucose turnover during moderate-intensity endurance exercise. American journal of physiology Regulatory, integrative and comparative physiology. 2006, 291 (4): R1120-1128. Basu R, Basu A, Chandramouli V, Norby B, Dicke B, Shah P, Cohen O, Landau B, Rizza R: Effects of pioglitazone and metformin on NEFA-induced insulin resistance in type 2 diabetes. Diabetologia. 2008, 51 (11): 2031-2040. 10.1007/s00125-008-1138-1. Tipton KD: Gender differences in protein metabolism. Current opinion in clinical nutrition and metabolic care. 2001, 4 (6): 493-498. 10.1097/00075197-200111000-00005. Lamont LS: Gender differences in amino acid use during endurance exercise. Nutrition reviews. 2005, 63 (12 Pt 1): 419-422. 10.1111/j.1753-4887.2005.tb00116.x.